Contact allergy to progesterone and estradiol in a patient with multiple corticosteroid allergies

Dermatitis

Volumn 15, Issue 2, 2004, Pages 78-81

  Lamb, Steven R ^a   Wilkinson, S Mark ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCLOMETASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BUDESONIDE; CALCIUM; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; CORTICOSTEROID; DEXAMETHASONE; DIFLUCORTOLONE VALERATE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ETIDRONIC ACID; FLUDROXYCORTIDE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE ACETATE; HYDROCORTISONE BUTYRATE; HYDROXYPROGESTERONE; MEDROXYPROGESTERONE; MOMETASONE FUROATE; PREMPAK; PROGESTERONE; SALICYLIC ACID; TIXOCORTOL PIVALATE; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTACT ALLERGY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROSS REACTION; DRUG HYPERSENSITIVITY; FEMALE; FOOT DISEASE; HAND DISEASE; HUMAN; MULTIPLE CORTICOSTEROID ALLERGY; NAUSEA; PATCH TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 4143078051     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.2310/6620.2004.03033     Document Type: Article

References (16)

1. Department of Health and Government Statistical Service. Prescription cost analysis, England 2002. United Kingdom: Government Statistical Service; 2003. p. 347-51.
2. Wilkinson SM. Hypersensitivity to topical corticosteroids. Clin Exp Dermatol 1994;19:1-11.
3. Thomson KF, Wilkinson SM, Powell S, Beck MH. The prevalence of corticosteroid allergy in two U.K. centres: prescribing implications. Br J Dermatol 1999;141:863-6.
4. English JS. Corticosteroid-induced contact dermatitis: a pragmatic approach. Clin Exp Dermatol 2000;25:261-4.
5. Koch P. Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch. Contact Dermatitis 2001;44:112-3.
6. Wilkinson SM, Beck MH. The significance of positive patch tests to 17-hydroxyprogesterone. Contact Dermatitis 1994;30:302-3.
7. Holdiness MR. A review of contact dermatitis associated with transdermal therapeutic systems. Contact Dermatitis 1989;20: 3-9.
8. Utian WH. Transdermal estradiol overall safety profile. Am J Obstet Gynecol 1987;156:1335-8.
9. Quirce S, Garde A, Baz G, et al. Allergic contact dermatitis from estradiol in a transdermal therapeutic system. Allergy 1996;51: 62-3.
10. Goncalo M, Oliveira HS, Monteiro C, et al. Allergic and systemic contact dermatitis from estradiol. Contact Dermatitis 1999;40: 58-9.
11. Corazza M, Mantovani L, Montanari A, Virgili A. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report. J Reprod Med 2002;47: 507-9.
12. Boehncke WH, Gall H. Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orally. Contact Dermatitis 1996;35: 187-8.
13. Shelley WB, Shelley ED, Talanin NY, Santoso-Pham J. Estrogen dermatitis. J Am Acad Dermatol 1995;32:25-31.
14. Wilkinson SM, Beck MH, Kingston TP. Progesterone-induced urticaria-need it be autoimmune? Br J Dermatol 1995;133: 792-4.
15. Stephens CJ, McFadden JP, Black MM, Rycroft RJ. Autoimmune progesterone dermatitis: absence of contact sensitivity to glucocorticoids, oestrogen and 17-alpha-OH-progesterone. Contact Dermatitis 1994;31:108-10.
16. Ventura MT, Calogiuri GF, Matino MG, et al. Alternative glucocorticoids for use in cases of adverse reaction to systemic glucocorticoids: a study on 10 patients. Br J Dermatol 2003;148: 139-41.